Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA:688621)
China · Delayed Price · Currency is CNY 66.45
+1.05 (1.61%)
Aug 20, 2026, 3:00 PM CST
SHA:688621 Market Cap
SHA:688621 has a market cap or net worth of 7.15 billion as of August 20, 2026. Its market cap has decreased by -20.64% in one year.
Market Cap
7.15B
Enterprise Value
7.35B
Revenue
1.19B
Ranking
n/a
PE Ratio
37.20
Stock Price
66.45
ChartMarket Cap Chart
Since June 21, 2021, SHA:688621's market cap has decreased from 9.61B to 7.15B, a decrease of -25.61%. That is a compound annual growth rate of -5.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 7.15B | 5.23% |
| Dec 31, 2025 | 6.79B | 60.85% |
| Dec 31, 2024 | 4.22B | -45.95% |
| Dec 29, 2023 | 7.81B | -4.64% |
| Dec 30, 2022 | 8.19B | -15.79% |
| Dec 31, 2021 | 9.73B | 1.26% |
| Jun 21, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sunflower Pharmaceutical Group | 7.79B |
| Zhejiang Tianyu Pharmaceutical | 7.72B |
| Renhe Pharmacy Co.,Ltd | 7.57B |
| Guangxi Wuzhou Zhongheng Group | 7.42B |
| Jiangsu Yahong Meditech | 7.27B |
| Jiangsu Kanion Pharmaceutical | 7.24B |
| Dezhan Healthcare Company | 7.24B |
| Northeast Pharmaceutical Group | 7.15B |